Skip to main content
Top
Published in: Clinical Rheumatology 9/2019

01-09-2019 | Streptococci | Case Based Review

Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series

Authors: Amir Dagan, Shani Dahan, Asaf Shemer, Pnina Langevitz, Tamer Hellou, Tima Davidson, Yehuda Shoenfeld, Ora Shovman

Published in: Clinical Rheumatology | Issue 9/2019

Login to get access

Abstract

Streptococcus is well associated with a myriad of inflammatory diseases. Among others, this bacterium is linked to the triggering of psoriasis and to post-streptococcal reactive arthritis (PSRA), an arthritis which is typically confined to peripheral joints. Three patients who developed acute psoriatic spondyloarthritis (SpA) following a recent streptococcal infection are described in this article. We searched the existing literature for cases of axial involvement in PSRA and reviewed the association between streptococcal infection and psoriasis or psoriatic arthritis )PsA). In all patients, psoriatic SpA occurred within 7–10 days of a confirmed streptococcal infection. The main presenting syndrome was inflammatory back pain with evidence of acute axial spondyloarthritis on magnetic resonance imaging. One patient had guttate psoriasis, the second patient developed pustular psoriasis, and the third patient had exacerbation of pustular palmoplantar psoriasis. Two patients required treatment with tumor necrosis factor alpha (TNF-α) blockers. Axial involvement in PSRA is very rare. A potential association of streptococcal infection and development of PsA has been explored in several articles. However, to the best of our knowledge, acute psoriatic SpA as a manifestation of PSRA has yet to be described. Acute psoriatic SpA should be considered in the differential diagnosis of new-onset inflammatory back pain followed by psoriasis in young adults who had a recent throat infection.

Key Points

Our case series describes three cases of acute psoriatic spondyloarthritis that occurred within 7–-10 days of a confirmed streptococcal infection and progressed to full blown chronic disease.
Acute psoriatic spondyloarthritis as a manifestation of post streptococcal reactive arthritis should be considered in the differential diagnosis of new onset inflammatory back pain followed by psoriasis in young adults who had a recent throat infection.
Literature
2.
go back to reference Hahn RG, Knox LM, Forman TA (2005) Evaluation of poststreptococcal illness. Am Fam Physician 71:1949–1954PubMed Hahn RG, Knox LM, Forman TA (2005) Evaluation of poststreptococcal illness. Am Fam Physician 71:1949–1954PubMed
3.
go back to reference Dajani AS, Ayoub E, Bierman FZ et al (1992) Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 268:2069–2073CrossRef Dajani AS, Ayoub E, Bierman FZ et al (1992) Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 268:2069–2073CrossRef
4.
go back to reference Ayoub EM, Ahmed S (1997) Update on complications of group A streptococcal infections. Curr Probl Pediatr 27:90–101PubMed Ayoub EM, Ahmed S (1997) Update on complications of group A streptococcal infections. Curr Probl Pediatr 27:90–101PubMed
5.
go back to reference Ahmed S, Ayoub EM, Scornik JC, Wang CY, She JX (1998) Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41:1096–1102CrossRefPubMed Ahmed S, Ayoub EM, Scornik JC, Wang CY, She JX (1998) Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41:1096–1102CrossRefPubMed
6.
go back to reference Mackie SL, Keat A (2004) Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 43:949–954CrossRef Mackie SL, Keat A (2004) Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 43:949–954CrossRef
7.
go back to reference Sarakbi HA, Hammoudeh M, Kanjar I, al-Emadi S, Mahdy S, Siam A (2010) Poststreptococcal reactive arthritis and the association with tendonitis, tenosynovitis, and enthesitis. J Clin Rheumatol 16:3–6CrossRefPubMed Sarakbi HA, Hammoudeh M, Kanjar I, al-Emadi S, Mahdy S, Siam A (2010) Poststreptococcal reactive arthritis and the association with tendonitis, tenosynovitis, and enthesitis. J Clin Rheumatol 16:3–6CrossRefPubMed
9.
go back to reference Dogan Durana U, Demir Y, Adiguzel E et al (2014) A rare adult case of sacroiliitis due to poststreptococcal reactive arthritis. Ann Phys Rehabil Med 57(Supplement 1):e253CrossRef Dogan Durana U, Demir Y, Adiguzel E et al (2014) A rare adult case of sacroiliitis due to poststreptococcal reactive arthritis. Ann Phys Rehabil Med 57(Supplement 1):e253CrossRef
10.
go back to reference Muşetescu AE, Florea M, ForŢofoiu MC, Bumbea AM, Tudorancea AD, Criveanu C, GofiŢă C, Ciurea PL, Ştefănescu A, Dinescu ŞC, Mogoantă CA (2017) Streptococcal tonsillitis related reactive arthritis - clinical, ultrasound imaging and immunohistochemical study. Romanian J Morphol Embryol 58:801–807 Muşetescu AE, Florea M, ForŢofoiu MC, Bumbea AM, Tudorancea AD, Criveanu C, GofiŢă C, Ciurea PL, Ştefănescu A, Dinescu ŞC, Mogoantă CA (2017) Streptococcal tonsillitis related reactive arthritis - clinical, ultrasound imaging and immunohistochemical study. Romanian J Morphol Embryol 58:801–807
11.
12.
go back to reference Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatol Venereol 29:415–424CrossRefPubMed Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatol Venereol 29:415–424CrossRefPubMed
13.
go back to reference Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490–495CrossRefPubMed Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490–495CrossRefPubMed
14.
go back to reference Brandon A, Mufti A, Gary Sibbald R (2019) Diagnosis and management of cutaneous psoriasis: a review. Adv Skin Wound Care 32:58–69CrossRefPubMed Brandon A, Mufti A, Gary Sibbald R (2019) Diagnosis and management of cutaneous psoriasis: a review. Adv Skin Wound Care 32:58–69CrossRefPubMed
15.
go back to reference Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149:530–534CrossRefPubMed Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149:530–534CrossRefPubMed
17.
go back to reference Kobayashi S, Tamura N, Ikeda M, Sakuraba K, Matsumoto T, Hashimoto H (2002) Uveitis in adult patients with poststreptococcal reactive arthritis: the first two cases reported associated with uveitis. Clin Rheumatol 21:533–535CrossRefPubMed Kobayashi S, Tamura N, Ikeda M, Sakuraba K, Matsumoto T, Hashimoto H (2002) Uveitis in adult patients with poststreptococcal reactive arthritis: the first two cases reported associated with uveitis. Clin Rheumatol 21:533–535CrossRefPubMed
18.
go back to reference Thrastardottir T, Love TJ (2018) Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review. Rheumatol Int 38:1385–1397CrossRefPubMed Thrastardottir T, Love TJ (2018) Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review. Rheumatol Int 38:1385–1397CrossRefPubMed
19.
go back to reference Vasey FB, Deitz C, Fenske NA (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9:719–722PubMed Vasey FB, Deitz C, Fenske NA (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9:719–722PubMed
20.
go back to reference Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH (1999) V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 42:2055–2059CrossRefPubMed Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH (1999) V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 42:2055–2059CrossRefPubMed
21.
go back to reference Thumboo J, Uramoto K, Shbeeb MI et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 29:757–762PubMed Thumboo J, Uramoto K, Shbeeb MI et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 29:757–762PubMed
22.
go back to reference Queiro R, Morante I, Cabezas I, Acasuso B (2016) HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford) 55:221–229CrossRef Queiro R, Morante I, Cabezas I, Acasuso B (2016) HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford) 55:221–229CrossRef
24.
go back to reference Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, Gudjonsson JE, Johnston A (2009) Psoriasis--as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494–501CrossRefPubMed Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, Gudjonsson JE, Johnston A (2009) Psoriasis--as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494–501CrossRefPubMed
25.
go back to reference Diani M, Altomare G, Reali E (2015) T cell responses in psoriasis and psoriatic arthritis. Autoimmun Rev 14:286–292CrossRefPubMed Diani M, Altomare G, Reali E (2015) T cell responses in psoriasis and psoriatic arthritis. Autoimmun Rev 14:286–292CrossRefPubMed
27.
go back to reference Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW (2014) Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheum 66:1272–1281CrossRef Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW (2014) Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheum 66:1272–1281CrossRef
28.
go back to reference Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N (2007) Use of adalimumab in poststreptococcal reactive arthritis. J Clin Rheumatol 13:176CrossRefPubMed Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N (2007) Use of adalimumab in poststreptococcal reactive arthritis. J Clin Rheumatol 13:176CrossRefPubMed
29.
go back to reference van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TWJ, Bax JJ, van der Helm-van Mil AHM (2009) No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum 60:987–993CrossRefPubMed van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TWJ, Bax JJ, van der Helm-van Mil AHM (2009) No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum 60:987–993CrossRefPubMed
30.
go back to reference Aviles RJ, Ramakrishna G, Mohr DN, Michet CJ Jr (2000) Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc 75:144–147CrossRefPubMed Aviles RJ, Ramakrishna G, Mohr DN, Michet CJ Jr (2000) Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc 75:144–147CrossRefPubMed
Metadata
Title
Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series
Authors
Amir Dagan
Shani Dahan
Asaf Shemer
Pnina Langevitz
Tamer Hellou
Tima Davidson
Yehuda Shoenfeld
Ora Shovman
Publication date
01-09-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04695-y

Other articles of this Issue 9/2019

Clinical Rheumatology 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.